View clinical trials related to Malignant Neoplasm.
Filter by:This study is a single-center, open, dose-escalation Phase I clinical study. It is designed to evaluate the safety, tolerability, preliminary efficacy and immunogenicity of treating NV-001, a king of hybrid-membrane-based tumor vaccine in patients with advanced solid tumors.
The goal of this research study is to understand the effect of inhalation approaches in reducing nausea in cancer patients.